Robert Langer wins 2019 Dreyfus Prize for Chemistry in Support of Human Health
Institute professor is honored for transformative work in drug delivery and tissue engineering.
Measuring chromosome imbalance could clarify cancer prognosis
A study of prostate cancer finds “aneuploid” tumors are more likely to be lethal than tumors with normal chromosome numbers.
Ashwin Sah, Megan Yamoah, and Steven Truong named 2019-20 Goldwater Scholars
Three MIT undergraduates honored for their academic achievements.
Using AI to predict breast cancer and personalize care
MIT/MGH's image-based deep learning model can predict breast cancer up to five years in advance.
3Q: Susan Hockfield on a new age of living machines
Convergence research at MIT and beyond seeks new solutions for global challenges.
A new approach to targeting tumors and tracking their spread
Researchers develop nanosized antibodies that home in on the meshwork of proteins surrounding cancer cells.
Three from MIT elected to the National Academy of Sciences for 2019
Faculty members Edward Boyden, Paula Hammond, and Aviv Regev recognized for “distinguished and continuing achievements in original research.”
Department of Biology hosts second annual Science Slam
Eight biology contestants get one slide and three minutes to explain their research and impress their listeners.
Nanoparticles take a fantastic, magnetic voyage
Tiny robots powered by magnetic fields could help drug-delivery nanoparticles reach their targets.
Imaging system helps surgeons remove tiny ovarian tumors
More effective surgery could boost survival rates for ovarian cancer.
The fluid that feeds tumor cells
The substance that bathes tumors in the body is quite different from the medium used to grow cancer cells in the lab, biologists report.
Meenakshi Chakraborty named 2019 Churchill Scholar
Senior majoring in computer science and molecular biology will pursue an MPhil at Cambridge University.
A new approach to drugging a difficult cancer target
Study suggests an alternative way to treat tumors that are dependent on the cancer-promoting Myc protein.
“Inactive” ingredients may not be, study finds
Most pills contain compounds with potential to cause allergic reactions or discomfort in some patients.